Partner Content Partner Content How to innovate and influence people in times of misinformat... Rewind to late 2019.
News Jazz gets first FDA nod for HER2 bispecific Ziihera Jazz Pharma has claimed FDA approval for its HER2-directed bispecific antibody Ziihera as a treatment for biliary tract cancer
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
